:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Author:	Castellini, Arianna
Format:	Recurso digital
Language:
Published:	Zenodo 2026
Online Access:	https://doi.org/10.5281/zenodo.19706924
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Decoding Dysregulation of DNA Methylation in Epigenetics of Idiopathic Pulmonary Fibrosis
by: Guorao Wu, et al.
Published: (2026)

Regulated Cell Death in Idiopathic Pulmonary Fibrosis
by: Xiaoyue Pan, et al.
Published: (2026)

Somatic Mutation Analysis of Mucin Genes and Pathways in Idiopathic Pulmonary Fibrosis
by: Seo, Mikyoung
Published: (2025)

Integrative Analysis of Endothelial Cell Senescence‐Related Genes in Idiopathic Pulmonary Fibrosis
by: Jianqiao Chen, et al.
Published: (2025)

Cytokine Expression Profiling in Idiopathic Pulmonary Fibrosis: Insights From Integrative Proteomic Analysis
by: Chenyou Shen, et al.
Published: (2025)

Regulatory T Cell Phenotype Related to Cytokine Expression Patterns in Post‐COVID‐19 Pulmonary Fibrosis and Idiopathic Pulmonary Fibrosis
by: Sara Gangi, et al.
Published: (2025)

Immunological Features and Potential Biomarkers of Systemic Sclerosis–Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis
by: Shuai Shao, et al.
Published: (2025)

Impact of Pirfenidone on Arrhythmic and Clinical Outcomes in Patients With Idiopathic Pulmonary Fibrosis
by: Sung Il Im, et al.
Published: (2026)

The Role of p53‐Mediated Cellular Senescence in Idiopathic Pulmonary Fibrosis
by: Yueyuan Jin, et al.
Published: (2025)

Role of Immune Cells in Mediating the Effect of Hypothyroidism on Idiopathic Pulmonary Fibrosis
by: Zhengling Liu, et al.
Published: (2025)

Retracted: Identification and Validation of Potential Biomarkers and Pathways for Idiopathic Pulmonary Fibrosis by Comprehensive Bioinformatics Analysis
by: BioMed Research International
Published: (2024)

Patient‐Reported Outcome Scale for Idiopathic Pulmonary Fibrosis: Development and Validation in China
by: Yang Xie, et al.
Published: (2024)

Causal Link and Shared Biomarkers Between Rheumatoid Arthritis and Idiopathic Pulmonary Fibrosis
by: Xixi Pan, et al.
Published: (2025)

Surgical lung biopsy for Idiopathic Pulmonary Fibrosis: Is the risk–benefit ratio changing
by: Ian N. Glaspole, et al.
Published: (2024)

Pulmonary‐Targeted Nanoparticles Interrupt the Malignant Mechanical and Biochemical Signaling Crosstalk for Idiopathic Pulmonary Fibrosis Therapy
by: Xue‐Na Li, et al.
Published: (2025)

Cell‐Surface LAMP1 is a Senescence Marker in Aging and Idiopathic Pulmonary Fibrosis
by: Gabriel Meca‐Laguna, et al.
Published: (2025)

OGG1: An emerging multifunctional therapeutic target for the treatment of diseases caused by oxidative DNA damage
by: Yunxiao Zhong, et al.
Published: (2024)

When DNA damage responses meet tumor immunity: From mechanism to therapeutic opportunity
by: Dong Pan, et al.
Published: (2024)

Idiopathic Pulmonary Haemorrhage, Is It Really Idiopathic?
by: Stefanie Louey, et al.
Published: (2025)

Molecular Pathways in Idiopathic Pulmonary Fibrosis: A Review of Novel Insights for Drug Design
by: Dilay Kahvecioglu
Published: (2025)

Comparison of Retrospective Motion Compensation Techniques for Pulmonary Dynamic Ultrashort Time to Echo MRI in Suspected Idiopathic Pulmonary Fibrosis
by: Abhilash S. Kizhakke Puliyakote, et al.
Published: (2026)

Nintedanib Lacks Efficacy in a Spirometry‐Confirmed and Bleomycin‐Induced Mouse Model of Idiopathic Pulmonary Fibrosis
by: Jamal Bousamaki, et al.
Published: (2026)

Bidirectional Mendelian Randomization Study: Unraveling the Link Between Idiopathic Pulmonary Fibrosis and Cardiovascular Disease
by: Lijuan Hu, et al.
Published: (2025)

Luteolin‐Loaded Hyaluronidase Nanoparticles with Deep Tissue Penetration Capability for Idiopathic Pulmonary Fibrosis Treatment
by: Bo Pan, et al.
Published: (2024)

Double Braking Effects of Nanomedicine on Mitochondrial Permeability Transition Pore for Treating Idiopathic Pulmonary Fibrosis
by: An Lu, et al.
Published: (2024)

Pre‐Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients
by: Roger M. Li, et al.
Published: (2025)

Different Levels of Autophagy Activity in Mesenchymal Stem Cells Are Involved in the Progression of Idiopathic Pulmonary Fibrosis
by: Hongxia Tao, et al.
Published: (2024)

Performance of an Idiopathic Pulmonary Fibrosis–Derived Multibiomarker Panel for Rheumatoid Arthritis–Associated Interstitial Lung Disease
by: Brent A. Luedders, et al.
Published: (2026)

CIResDiff: A Clinically-Informed Residual Diffusion Model for Predicting Idiopathic Pulmonary Fibrosis Progression
by: Jiang, Caiwen, et al.
Published: (2024)

Idiopathic Pulmonary Fibrosis Is Associated With Type 1 Diabetes: A Two‐Sample Mendelian Randomization Study
by: Leyan Chen, et al.
Published: (2025)

Exertional Desaturation and Ambulatory Oxygen Therapy Requirements in People with Idiopathic Pulmonary Fibrosis. A Retrospective Study
by: Tamara Soler
Published: (2025)

Association Between Single Nucleotide Polymorphisms and Disease Susceptibility, Survival, and Acute Exacerbation in Idiopathic Pulmonary Fibrosis
by: Kazuya Tsubouchi, et al.
Published: (2025)

Development and Validation of a Clinical Scoring System Predicting 30‐Day Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
by: Joong‐Yub Kim, et al.
Published: (2025)

Targeting the DNA damage response in cancer
by: Federica Guffanti, et al.
Published: (2024)

A novel DNA damage detection method based on a distinct DNA damage response system
by: Shitong Zhong, et al.
Published: (2024)

Krylov Iterative Methods for the Geometric Mean of Two Matrices Times a Vector
by: Castellini, Jacopo
Published: (2019)

Prognostic Model for Idiopathic Pulmonary Fibrosis Using Context-Aware Sequential-Parallel Hybrid Transformer and Enriched Clinical Information
by: Dolatabadi, Mahdie, et al.
Published: (2025)

Transbronchial Cryoablation for Early‐Stage Non‐Small Cell Lung Cancer of the Central Airway Complicated by Idiopathic Pulmonary Fibrosis
by: Masamitsu Hamakawa, et al.
Published: (2025)

Hesperetin Mitigate Idiopathic Pulmonary Fibrosis by Regulating Gut Microbiota and Acetate and Butyrate Levels via the Gut‐Lung Axis
by: Xia Meng, et al.
Published: (2025)

ISABELA Studies: Plasma Exposure and Target Engagement Do Not Explain the Lack of Efficacy of Ziritaxestat in Patients with Idiopathic Pulmonary Fibrosis
by: Amit Taneja, et al.
Published: (2024)